CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, citing the example of annual flu-shot revisions.
https://ift.tt/fiXJMEy
from WebMD Health https://ift.tt/xtDYMyu
by
Comments
Post a Comment